Family Consultation to Reduce Early Hospital Readmissions among Patients with End Stage Kidney Disease A Randomized Controlled Trial

被引:8
|
作者
Jasinski, Matthew J. [1 ]
Lumley, Mark A. [1 ]
Soman, Sandeep [2 ]
Yee, Jerry [2 ]
Ketterer, Mark W. [3 ]
机构
[1] Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Floor, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Henry Ford Hosp, Dept Nephrol, Detroit, MI USA
[3] Henry Ford Hlth Syst, Henry Ford Hosp, Dept Psychiat, Detroit, MI USA
关键词
Adult; Centers for Medicare and Medicaid Services (US); chronic kidney failure; Cognition; Cognitive Dysfunction; Emergency Service; Hospital; Humans; Inpatients; Kidney Failure; Chronic; Literacy; Logistic Models; Male; Medicaid; Medical Records; Medicare; Middle Aged; nephrology; Patient Discharge; Patient Readmission; Referral and Consultation; risk factors; Social Support; Telephone; United States; IMMUNOSUPPRESSANT THERAPY ADHERENCE; COGNITIVE IMPAIRMENT; SOCIAL SUPPORT; CARE; RISK; PREVALENCE; MEDICINE; IMPACT; ADULTS;
D O I
10.2215/CJN.08450817
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The US Centers for Medicare and Medicaid Services have mandated reducing early (30-day) hospital readmissions to improve patient care and reduce costs. Patients with ESKD have elevated early readmission rates, due in part to complex medical regimens but also cognitive impairment, literacy difficulties, low social support, and mood problems. We developed a brief family consultation intervention to address these risk factors and tested whether it would reduce early readmissions. Design, setting, participants, & measurements One hundred twenty hospitalized adults with ESKD (mean age=58 years; 50% men; 86% black, 14% white) were recruited from an urban, inpatient nephrology unit. Patients were randomized to the family consultation (n=60) or treatment-as-usual control (n=60) condition. Family consultations, conducted before discharge at bedside or via telephone, educated the family about the patient's cognitive and behavioral risk factors for readmission, particularly cognitive impairment, and how to compensate for them. Blinded medical record reviews were conducted 30 days later to determine readmission status (primary outcome) and any hospital return visit (readmission, emergency department, or observation; secondary outcome). Logistic regressions tested the effects of the consultation versus control on these outcomes. Results Primary analyses were intent-to-treat. The risk of a 30-day readmission after family consultation (n=12, 20%) was 0.54 compared with treatment-as-usual controls (n=19, 32%), although this effect was not statistically significant (odds ratio, 0.54; 95% confidence interval, 0.23 to 1.24; P=0.15). A similar magnitude, nonsignificant result was observed for any 30-day hospital return visit: family consultation (n=19, 32%) versus controls (n=28, 47%; odds ratio, 0.53; 95% confidence interval, 0.25 to 1.1; P=0.09). Per protocol analyses (excluding three patients who did not receive the assigned consultation) revealed similar results. Conclusions A brief consultation with family members about the patient's cognitive and psychosocial risk factors had no significant effect on 30-day hospital readmission in patients with ESKD.
引用
收藏
页码:850 / 857
页数:8
相关论文
共 50 条
  • [21] A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients
    Sellors, J
    Kaczorowski, J
    Sellors, C
    Dolovich, L
    Woodward, C
    Willan, A
    Goeree, R
    Cosby, R
    Trim, K
    Sebaldt, R
    Howard, M
    Hardcastle, L
    Poston, J
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2003, 169 (01) : 17 - 22
  • [22] Evaluation of 30-Day hospital readmissions for patients with end stage renal disease
    Dees, Cassandra
    Hudson, Joanna Q.
    Apple, Alison
    Womeodu, Robin
    Duhart, Benjamin T., Jr.
    PHARMACOTHERAPY, 2015, 35 (11): : E278 - E279
  • [23] Acupressure and quality of sleep in patients with end-stage renal disease - a randomized controlled trial
    Tsay, SL
    Chen, ML
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2003, 40 (01) : 1 - 7
  • [24] DEVELOPMENT OF AN INTEGRATED END-STAGE KIDNEY DISEASE CARE COORDINATION MODEL: A RANDOMIZED CONTROLLED TRIAL PROTOCOL
    Roer, David
    Maris, Tabitha
    Davda, Rajesh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 626 - 627
  • [25] Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial
    Moryousef, Joseph
    Bortolussi-Courval, Emilie
    Podymow, Tiina
    Lee, Todd C.
    Trinh, Emilie
    McDonald, Emily G.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2022, 9
  • [26] Early Hospital Readmissions Among Patients With Inflammatory Bowel Disease in the United States
    Tinsley, Andrew
    Wang, Li
    Williams, Emmanuelle
    Ullman, Thomas A.
    Sands, Bruce E.
    GASTROENTEROLOGY, 2013, 144 (05) : S646 - S646
  • [27] ANALYZING HOSPITAL READMISSIONS IN END-STAGE RENAL DISEASE PATIENTS WITH AND WITHOUT HEART FAILURE
    Ustaris, Linda-Marie
    Goolsarran, Nirvani
    Mallipattu, Sandeep
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 592 - 592
  • [28] Telemedicine Reduces Cirrhosis-Related Hospital Readmissions in Patients With End Stage Liver Disease
    Hong, Inki
    Kalman, Richard
    Navarro, Victor J.
    Rossi, Simona
    Verma, Manisha
    Walter, James
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S572 - S573
  • [29] Predischarge Bundle for Patients With Acute Exacerbations of COPD to Reduce Readmissions and ED Visits A Randomized Controlled Trial
    Jennings, Jeffrey H.
    Thavarajah, Krishna
    Mendez, Michael P.
    Eichenhorn, Michael
    Kvale, Paul
    Yessayan, Lenar
    CHEST, 2015, 147 (05) : 1227 - 1234
  • [30] Effect of immunonutrition on inflammatory markers among end-stage liver disease patients referred for liver transplantation: Randomized controlled trial
    Beevi, S. S. Safeena
    Pottakkat, Biju
    Mohan, Pazhanivel
    Vairappan, Balasubramaniyan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 104 - 104